secwatch / observer
8-K filed May 20, 2025, 7:59 PM ET ticker WENN CIK 0002057043
other material confidence high sentiment neutral materiality 0.60

Wen Acquisition Corp closes $300.15M IPO, proceeds placed in trust

WEN Acquisition Corp

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Sheraz Shere

Chair of the Compensation Committee
WENN · WEN Acquisition Corp
Effective
2025-05-15
Filed
May 20, 2025, 7:59 PM ET
Each of Mr. Fried, Mr. Shere and Mr. Glover was appointed to the Board’s Compensation Committee, with Mr. Shere serving as chair of the Compensation Committee.
Appointed

Josh Fried

Director
WENN · WEN Acquisition Corp
Effective
2025-05-15
Filed
May 20, 2025, 7:59 PM ET
On May 15, 2025, in connection with the IPO Josh Fried, Sheraz Shere and Drew Glover (collectively with Julian M. Sevillano, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).
Appointed

Sheraz Shere

Co-Vice Chairman of the Board
WENN · WEN Acquisition Corp
Effective
2025-05-15
Filed
May 20, 2025, 7:59 PM ET
In addition, each of Sheraz Shere and Josh Fried was appointed to serve as Co-Vice Chairman of the Board.
Appointed

Josh Fried

Co-Vice Chairman of the Board
WENN · WEN Acquisition Corp
Effective
2025-05-15
Filed
May 20, 2025, 7:59 PM ET
In addition, each of Sheraz Shere and Josh Fried was appointed to serve as Co-Vice Chairman of the Board.
Appointed

Drew Glover

Chair of the Audit Committee
WENN · WEN Acquisition Corp
Effective
2025-05-15
Filed
May 20, 2025, 7:59 PM ET
each of Mr. Fried, Mr. Shere and Mr. Glover was appointed to the Board’s Audit Committee, with Mr. Glover serving as chair of the Audit Committee.
Appointed

Sheraz Shere

Director
WENN · WEN Acquisition Corp
Effective
2025-05-15
Filed
May 20, 2025, 7:59 PM ET
On May 15, 2025, in connection with the IPO Josh Fried, Sheraz Shere and Drew Glover (collectively with Julian M. Sevillano, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).
Appointed

Drew Glover

Director
WENN · WEN Acquisition Corp
Effective
2025-05-15
Filed
May 20, 2025, 7:59 PM ET
On May 15, 2025, in connection with the IPO Josh Fried, Sheraz Shere and Drew Glover (collectively with Julian M. Sevillano, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Sheraz Shere was appointed as Chair of the Compensation Committee at WEN Acquisition Corp.

Action
appointed
Role
Chair of the Compensation Committee
Exact text from the filing
Each of Mr. Fried, Mr. Shere and Mr. Glover was appointed to the Board’s Compensation Committee, with Mr. Shere serving as chair of the Compensation Committee.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 1.0

Josh Fried was appointed as Director at WEN Acquisition Corp.

Action
appointed
Role
Director
Exact text from the filing
On May 15, 2025, in connection with the IPO Josh Fried, Sheraz Shere and Drew Glover (collectively with Julian M. Sevillano, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 1.0

Sheraz Shere was appointed as Co-Vice Chairman of the Board at WEN Acquisition Corp.

Action
appointed
Role
Co-Vice Chairman of the Board
Exact text from the filing
In addition, each of Sheraz Shere and Josh Fried was appointed to serve as Co-Vice Chairman of the Board.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 1.0

Josh Fried was appointed as Co-Vice Chairman of the Board at WEN Acquisition Corp.

Action
appointed
Role
Co-Vice Chairman of the Board
Exact text from the filing
In addition, each of Sheraz Shere and Josh Fried was appointed to serve as Co-Vice Chairman of the Board.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 1.0

Drew Glover was appointed as Chair of the Audit Committee at WEN Acquisition Corp.

Action
appointed
Role
Chair of the Audit Committee
Exact text from the filing
each of Mr. Fried, Mr. Shere and Mr. Glover was appointed to the Board’s Audit Committee, with Mr. Glover serving as chair of the Audit Committee.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 1.0

Sheraz Shere was appointed as Director at WEN Acquisition Corp.

Action
appointed
Role
Director
Exact text from the filing
On May 15, 2025, in connection with the IPO Josh Fried, Sheraz Shere and Drew Glover (collectively with Julian M. Sevillano, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 1.0

Drew Glover was appointed as Director at WEN Acquisition Corp.

Action
appointed
Role
Director
Exact text from the filing
On May 15, 2025, in connection with the IPO Josh Fried, Sheraz Shere and Drew Glover (collectively with Julian M. Sevillano, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).
View on SEC.gov
Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

WEN Acquisition Corp: The Company filed its amended and restated memorandum and articles of association, effective May 15, 2025, in connection with its IPO (effective 2025-05-15).

Change
charter amendment
Effective
2025-05-15
Exact text from the filing
On May 15, 2025, in connection with the IPO, the Company filed its amended and restated memorandum and articles of association (the “ Amended and Restated Memorandum and Articles of Association ”) with the Cayman Islands Registrar of Companies, which was effective on May 15, 2025.
View on SEC.gov

74 governance changes filed in the last 30 days. Browse all governance changes →

WEN Acquisition Corp filing history →

Source: SEC EDGAR
accession 0001213900-25-045513
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.